Deciphering a short text in mid-10th century Greek bookhand - β???????

Post date: 2021-03-05 03:36:33
Views: 381
On the basis of two online images of a meticulously lettered paragraph in two early copies of Dioscorides' De Materia Medica - one smaller, colour one from the Morgan manuscript, and one larger, more distinct, black&white one from the Vienna manuscript - would anyone be able to help transcribe and possibly translate the text? (My previous appeal for a classical Japanese page found great help from the hive mind!)

The text pertains to the first illustration on the page, of a stag's head - the inscription next to it (in the Morgan, above it in the Vienna) reads: "elaphou kephale" - and I am lead to believe (by a third, knowledgable source) the text actually deals with a kind of aphrodisiac tuber/fungus. It's part of a section absent from most other copies of Dioscorides seminal work, so I haven't been able to locate a version either transcribed or translated. And, full disclosure, I have no level of Greek, least of all its medieval majuscule bookhand version, so I'm kind of stuck... TIA for any pointers or assistance!
Number of Comments
Please click Here to read the full story.
 
Other Top and Latest Questions:
Stock futures are mixed as traders await Fed decision, Big Tech earnings: Live updates
Trump administration may let more Russian diesel onto market, energy secretary tells CNBC
Trump jokes $5,000 would buy 'a hamburger and maybe a small dessert' at Mar-a-Lago as cost of living looms over midterms
Indian investors rush to Nvidia, SpaceX, Apple as local trading apps roll out access to U.S. stocks
Boeing shares slide on a disappointing cash flow update. Why this dip is buyable
Trump says Iran war will end 'when I want it to' as costs reportedly balloon to $47 billion
Neighbour/community simulators?
Israel election appears to have no clear winner with Netanyahu, opponent Eisenkot far short of majorities
Chevron and Exxon hit all-time highs as refining profits soar in reaction to Iran and Ukraine wars
Intel heads for worst day on Wall Street in more than 50 years on weak guidance